摘要目的 评价中文版病耻感体验问卷(CESQ)在乳腺癌患者中应用的信度和效度,为关爱女性乳腺癌患者、降低病耻感水平,实施有效护理干预策略提供科学依据.方法 对英文版CESQ进行翻译、回译和文化调适,采用方便取样的方法选取2017年5月至2018年8月就诊的乳腺癌患者发放问卷200份,有效回收190份.随机抽取60例患者于2周后重测.使用SPSS21.0和AMOS21.0对调查数据进行信效度检验.结果 中文版CESQ在乳腺癌患者中应用Cronbachα系数为0.819,Guttman分半信度系数为0.844,各条目得分之间相关系数为0.405～0.809,各条目得分与CESQ总分相关系数为0.499～0.812(P<0.05).重测信度系数为0.898.4名专家对中文版CESQ进行评分,各条目内容效度指数为0.801～1.000,全体一致性内容效度指数为0.804,平均内容效度指数为0.830.采用主成分分析法进行探索性因子分析,经方差正交旋转后得到1个公因子,累计方差贡献率为55.65％.采用AMOS17.0对数据进行验证性因子分析得到各项拟合指数均达标,卡方/自由度比为1.200,拟合优度指数为0.909,近似误差均方根为0.069,规范拟合指数为0.957,相对适配指数为0.944,增值拟合指数为0.904,非归准适配指数为0.907,比较拟合指数为0.911,标准化回归系数为0.435～0.668.结论 中文版CESQ评价乳腺癌患者病耻感具有良好的信度和效度,对评价我国乳腺癌患者的病耻感具有应用价值.

abstractsObjective To evaluate the reliability and validity of the Chinese version of the Sickness Experience Questionnaire (CESQ) in breast cancer patients, and to provide a scientific basis for caring for female breast cancer patients and reducing the level of stigma. Methods The English version of CESQ was translated and culturally adjusted. 200 questionnaires were sent out to breast cancer patients in our hospital from May 2017 to August 2018 by convenient sampling method. 190 questionnaires were effectively recovered. Sixty patients were randomly selected and retested after 2 weeks. Reliability and validity was examined by SPSS21.0 and AMOS21.0. Results The Chinese version of CESQ scale Cronbach α coefficient was 0.819, Guttman′s split-half reliability coefficient was 0.844, the correlation coefficient between each item score was 0.405-0.809, and the correlation coefficient between each item score and CESQ total score was 0.499-0.812 (P<0.05). The test-retest&nbsp;reliability coefficient was 0.898. Four experts rated the Chinese version of CESQ with a content validity index of 0.801 to 1.000, an overall consistency content validity index CVI of 0.804, and an average content validity index of 0.830. Principal component analysis was used to conduct exploratory factor analysis. After the orthogonal rotation of the variance, one common factor was obtained, and the cumulative variance contribution rate was 55.65％. Using AMOS 17.0, the data was subjected to confirmatory factor analysis with a chi-square/degree-of-freedom ratio of 1.20 and a goodness-of-fit index of 0.909. The approximate error root mean square was 0.069, the gauge fit index was 0.957, the relative fit index was 0.944, and the value-added fit index was 0.904. Non-standard fit The index was 0.907, the comparative fit index was 0.911, and the normalized regression coefficient was 0.435-0.668. Conclusions The Chinese version of CESQ has a good reliability and validity in evaluating the stigma of breast cancer patients. It has application value in evaluating the stigma of breast cancer patients in China.